Zydus Lifesciences Limited Overview
Pro stress-test →Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad. The group ranks 4th in the Indian pharmaceutical industry and operates across generic pharmaceuticals, biosimilars, vaccines, and consumer wellness with a strong global footprint in regulated markets.
Strategic Profile
Pro stress-test →The company's growth has been driven by an expanding specialty portfolio, strong India business growth, a robust product pipeline and value-accretive acquisitions. Zydus maintains India's largest biosimilar portfolio with more than 13 biosimilars developed and manufactured domestically. The company expects its India formulations business to outperform the pharmaceutical market by 200-400 basis points, positioning it as a competitive player in high-growth domestic and international segments.
Competitive Landscape
Pro stress-test →Key competitors include Torrent Pharmaceuticals, Mankind Pharma, Ajanta Pharma, Natco Pharma, and Glenmark Pharmaceuticals. Zydus differentiates through its large domestically developed biosimilar portfolio and expanding specialty pharmaceutical capabilities, though it faces strong competition from larger generics-focused peers in the Indian pharmaceutical market.
Industry Context
Zydus Lifesciences Limited operates in Pharmaceutical generics and biosimilars.
Key facts
Founded: 1952 · Headquarters: Ahmedabad, India · Employees: 29,000 · Revenue: $2.93B (trailing twelve months) · Market cap: ₹1,10,826 crore (~$13.3B USD as of June 2026)